Daniel Glozman

Forsight Robotics Ltd. is a private company based in Israel that is revolutionizing ophthalmic surgery with their state-of-the-art robotics, advanced visualization, and data analytics. The Israeli company is developing oryom, the world's first robotic surgery platform for cataracts and widespread eye diseases, which will utilize AI-based algorithms, advanced computer vision, and miniaturized mechanics. Forsight Robotics is backed by highly recognized VCs and industry leaders, and is bringing hope to millions of patients worldwide. The company was founded by Moshe Shoham, Daniel Glozman, and Joseph Nathan, with Daniel Glozman serving as the CEO since incorporation.

Guide-X Ltd. develops medical devices for diagnosing cancerous diseases. It manufactures apparatus for insertion of needles for diagnosing cancerous diseases. The firm specializes in inserting a biopsy needle for diagnosis of lung cancer. The company was founded in 2007 and is headquartered in Kiryat Shmona, Israel.